a hologenomic approach that integrates methylation, mutation, and microbial signals, Origin generates comprehensive molecular profiles for disease detection and monitoring. The test is rapid (under two minutes), requires no patient preparation, and can be performed by a trained healthcare professional.

Origin’s lead application is the detection of colorectal cancer (CRC) and high-grade dysplasia, alongside identification of advanced adenomas and other actionable gastrointestinal pathology. The platform is also being developed for additional indications including inflammatory bowel disease and pancreatic cancer.